Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
Back
CAS
211915-06-9
Purity
95%
Dabigatran etexilate is an anticoagulant used for the prevention of venous thromboembolic events or stroke in patients with recent elective hip or knee replacement surgery and atrial fibrillation. It is an oral prodrug that is hydrolyzed to the competitive and reversible direct thrombin inhibitor dabigatran.
Properties
Name
Dabigatran etexilate
Smiles
CCCCCCOC(=O)N=C(N)C=1C=CC(NCC2=NC=3C=C(C=CC3N2C)C(=O)N(CCC(=O)OCC)C=4C=CC=CN4)=CC1
Targets
Please log in to see this information
dabigatran | dabigatran etexilate | pradax | pradaxa
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$19
45 mg
$19
50 mg
$19
75 mg
$19
100 mg
$19
Quantity
1
Total amount
$ 19
dabigatran | dabigatran etexilate | pradax | pradaxa
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
Powered by Bioz